Thomas Strüngmann

Thomas Strüngmann was the founder of ATS Beteiligungsverwaltung GmbH, founded in 2006, serving as Chief Executive Officer from 2010 to 2018.
Dr. Strüngmann is the founder of Athos KG, founded in 2019.
Dr. Strüngmann was the founder of Hexal AG, founded in 1986, serving as Unternehmensgründer from 1986 to 2010.
Dr. Strüngmann is also the founder of AT Newtec GmbH..
Dr. Strüngmann is Co-Managing Director at Klinge Pharma GmbH.
Dr. Strüngmann is Co-Managing Director at Dr. Ernst Strüngmann Foundation gGmbH.
Dr. Strüngmann is Co-Managing Director at Projektgesellschaft St. Anna 16 mbH.
Dr. Strüngmann is Co-Managing Director at Klinge Pharma GmbH (Bayern).
Dr. Strüngmann was Chairman at Eon Labs, Inc. Dr. Strüngmann was Chairman-Supervisory Board at Santo Holding AG.
Dr. Strüngmann was Co-Managing Director at ATHOS Service GmbH.
Dr. Strüngmann was Co-Managing Director at Jossa Arznei.
GmbH.
Dr. Strüngmann was Co-Managing Director at AT Impf GmbH.
Dr. Strüngmann was Member-Supervisory Board at Wacker Chemie AG.
Dr. Strüngmann was Member-Supervisory Board at Formycon AG from 2022 to 2023.
Dr. Strüngmann earned a doctorate from the University of Augsburg.
Dr. Strüngmann completed undergraduate studies at Ludwig-Maximilians-Universität München.